Decline in Pneumococcal Disease in Young Children During the Coronavirus Disease 2019 (COVID-19) Pandemic in Israel Associated With Suppression of Seasonal Respiratory Viruses, Despite Persistent Pneumococcal Carriage: A Prospective Cohort Study코로나바이러스 질병 2019(COVID-19) 동안 어린이의 폐렴구균 질병 감소, 지속적인 폐렴구균 감염에도 불구하고 계절성 호흡기 바이러스 억제와 관련된 이스라엘의 유행성: 전향적 코호트 연구Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 치료기술, [키워드] activity Adenovirus adjusted age alveolar Chain Reaction chest X-ray chest X-rays children Cohort colonization COVID-19 COVID-19 pandemic Decline declined density disappearance disease distribution Ethnicity expected followed by human metapneumovirus Hypothesis implicated incidence incidence rate Influenza influenza viruses invasive pneumococcal disease lockdown lower respiratory infections magnitude métapneumovirus monthly rate nasopharyngeal Nonpharmaceutical interventions nonpneumonia parainfluenza Pathogens persistent pneumococcal pneumococcal pneumoniae pneumococcus Pneumonia pneumoniae polymerase chain polymerase chain reaction Prevalence Previous studies previous study Prospective reduced reduction reductions respiratory respiratory infection respiratory infections respiratory syncytial virus respiratory virus respiratory viruses respiratory viruses. resulting rhinovirus SARS-CoV-2 seasonal serotype suppression Surveillance Transmission [DOI] 10.1093/cid/ciab1014 PMC 바로가기 [Article Type] Article
Comparison of Surface Persistence of SARS-CoV-2 Alpha and Delta Variants on Stainless Steel at 4°C and 24°C4°C 및 24°C에서 스테인리스강에 대한 SARS-CoV-2 알파 및 델타 변이체의 표면 지속성 비교Article Published on 2022-07-262022-09-11 Journal: Applied and Environmental Microbiology [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] Aerosols Alpha alpha and delta variants Alpha variant both virus both viruses conditions conducted contact with contaminated surface contaminated surfaces COVID-19 Delta delta variant detectable droplet Evidence fomites Human implication in some Intervention investigated log MOST occur persistence provide reduction reductions Region RNA RNA virus SARS-CoV-2 SARS-CoV-2 variants stability stainless steel steel Support surface surface persistence surface stability survival survived temperature through contact transfer Transmission transmission of SARS-CoV-2 variant winter transmission. [DOI] 10.1128/aem.00764-22 PMC 바로가기 [Article Type] Article
Illicit Substance Use and the COVID-19 Pandemic in the United States: A Scoping Review and Characterization of Research Evidence in Unprecedented Times불법 물질 사용 및 미국의 Covid-19 Pandemic : 전례없는시기에 연구 증거의 범위 검토 및 특성화Review Published on 2022-07-212022-08-31 Journal: International Journal of Environmental Research an [Category] MERS, 치료제, [키워드] access to treatment article carried change changes in characterization conducted COVID-19 COVID-19 pandemic database determinant effective response Evidence fentanyl harm reduction Health heroin illicit drugs Improved Increases increases in Intervention Limited majority medical record medical records medical service outcome overdose Prevent public health Quantitative Quantitative data reduction reductions reductions in review risk routine monitoring scoping review selected significantly substance Substance use substance use. supported the United State threshold time Treatment United States worsening [DOI] 10.3390/ijerph19148883 PMC 바로가기 [Article Type] Review
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strainsSARS-CoV-2 Omicron 계통 균주에 의한 감염에 대한 S309 및 AZD7442 단일클론 항체 치료의 회복력Article Published on 2022-07-022022-09-11 Journal: Nature Communications [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acting Antibody neutralization AstraZeneca Cell culture changes in Combination correlation analyses Correlation analysis Effect Efficacy Express FcγR hACE2 human ACE2 humans in vitro In vitro studies in vitro study in vivo Infection Interaction K18-hACE2 Lineage Lung infection mAb mechanism mice monoclonal antibody monoclonal antibody therapies monoclonal antibody treatment monotherapy neutralization neutralization potency Neutralizing activity omicron Omicron variant Omicron variants Prevent Prophylactic Protective reduced reductions reductions in Resilience retained S309 SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 isolates SARS-CoV-2 variant Spike protein strain suggested susceptible the spike protein therapeutic therapy transgenic mice treat Treatment variant variants Viral viral burden [DOI] 10.1038/s41467-022-31615-7 PMC 바로가기 [Article Type] Article
Modeling waning and boosting of COVID-19 in Canada with vaccination예방 접종으로 캐나다의 COVID-19 감소 및 증가 모델링Article Published on 2022-06-012022-09-11 Journal: Epidemics [Category] COVID19(2023년), SARS, 변종, [키워드] advent age Age structure benefit Canada causative agent caused change changes in Compliance COVID-19 COVID-19 epidemic COVID-19 infection COVID-19 vaccination decision Delay Delay of second dose of vaccine dose doses effective vaccine Effective vaccines globe Health Immunity Impact include Increases increases in Infection modeling protocol public health question reductions reductions in SARS-CoV-2 second dose second dose of vaccine social distancing the vaccine Transmissibility vaccinate vaccination Vaccine variants variants of concern virus waning immunity Waning Immunity. [DOI] 10.1016/j.epidem.2022.100583 PMC 바로가기 [Article Type] Article
Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series코로나바이러스 질병 2019 환자의 렘데시비르 항-CD20 단일클론항체 치료: 사례 시리즈Randomized Controlled Trial Published on 2022-06-012022-09-11 Journal: Infection [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료제, [키워드] administration anti-CD20 Anti-CD20 antibodies anti-CD20 treatment antiviral therapy approved baseline baseline data benefit Case series case sery Clinical improvement Clinical outcome consecutive patient control group convalescent plasma COVID-19 COVID-19 patient COVID-19 symptoms Diagnosis died disease course Follow-up healthcare Infection lack majority malignancy management median monoclonal not performed one patient outcomes pandemic Patient patient population patients patients died patients treated PCR performed Randomized controlled trial Randomized controlled trials reductions reductions in relapsing Remdesivir reported rituximab SARS-CoV-2 SARS-CoV-2. Study design symptom onset Symptoms These data Treatment two patients Viral viral clearance viral loads [DOI] 10.1007/s15010-022-01821-y PMC 바로가기 [Article Type] Randomized Controlled Trial
Evaluation of different types of face masks to limit the spread of SARS-CoV-2: a modeling studySARS-CoV-2의 확산을 제한하기 위한 다양한 유형의 안면 마스크 평가: 모델링 연구Article Published on 2022-05-232022-09-11 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] Asymptomatic B.1.1.529 B.1.617.2 basic reproductive number benefit complex COVID-19 COVID-19 incidence COVID-19 infection COVID-19 infections cumulative death effective Efficacy estimate Face mask Face masks group include limit Mask Masks mathematical mathematical model Medical procedure Mortality omicron parameters Population Prevalence reduced reductions reductions in Reproduction number reproductive risk SARS-CoV-2 transmission Spread The United States Transmission United States variant variants variants of concern variety wearing mask wearing masks [DOI] 10.1038/s41598-022-11934-x PMC 바로가기 [Article Type] Article
Infection fatality rate and infection attack rate of COVID-19 in South American countries남미 국가에서 COVID-19의 감염 치사율 및 감염 공격 비율Article Published on 2022-04-062022-09-11 Journal: Infectious Diseases of Poverty [Category] COVID19(2023년), SARS, 변종, [키워드] affected analysed Analysis attack rate center country Coverage COVID-19 COVID-19 mortality COVID-19 outbreak COVID-19 pandemic dataset death deaths epidemic model epidemiological estimate fatality Fatality rate flexible Formula Health Organization help heterogeneous highest highlight IFR Infection Infection attack rate Infection fatality rate Johns Hopkin Johns Hopkins measure mortalities mortality rate MOST nonpharmaceutical intervention observé pandemic parameter Protective reductions reductions in reported reproduction Reproduction number Reproduction number. retrieved reveal Severe infection severity situation social distancing South South America spatiotemporal suppress Surveillance text the disease transmission rate vaccination vaccination rate Variability variant World Health Organization [DOI] 10.1186/s40249-022-00961-5 PMC 바로가기 [Article Type] Article
Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis변종 및 예방접종 현황에 따른 SARS-CoV-2의 가구 2차 공격 비율: 업데이트된 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-04-012022-09-11 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% CIs affected Alpha article articles attack attack rate Beta changed changes in Contact covariate covariates COVID-19 Delta effective vaccine Effective vaccines Effectiveness eligible evaluate household household contacts household SAR Household SARs index case Infection infection rate infectiousness item linear mixed model meta-analyses number of household number of infected omicron outcome Probability Rate reductions reductions in reported Reporting review SAR SAR estimate SARS-CoV-2 SARS-CoV-2 variant secondary secondary attack rate Secondary infection stratified susceptibility susceptibility to infection synthesis systematic reviews Transmissibility Transmission transmission rates vaccination Vaccination Status Vaccine variant variants of concern viral evolution viral variant were used [DOI] 10.1001/jamanetworkopen.2022.9317 PMC 바로가기 [Article Type] Meta-Analysis
Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab중화 단일클론항체 밤라니비맙 치료 후 코로나19로 입원한 환자의 비인두 면봉 유전자 발현 패턴과 혈청 바이오마커 간의 관계Randomized Controlled Trial Published on 2022-03-182022-09-11 Journal: Journal of Translational Medicine [Category] SARS, 바이오마커, 유전자 메커니즘, 임상, 진단, 치료기술, [키워드] absence Analysis Analytes antibody formation Antibody Response approach bamlanivimab Biomarker biomarker signature Biomarkers Blood change changes in circulation clinical clinical trial Cohort collected connection coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 correlated COVID-19 CXCL10 CXCL11 detect disease Elecsys Gene Expression gene expression pattern groups healthy control healthy controls Hospitalized hospitalized COVID-19 patient hospitalized COVID-19 patients IFNγ IgA IgG titer IgG titers IgM IL-6 immune response immunoassay immunological implementation Infection Inflammatory inflammatory protein Inflammatory response interferon response Level Luminex MCP-3 MONITOR monoclonal antibody nasopharyngeal Nasopharyngeal swab nasopharyngeal swab sample Nasopharyngeal swab samples nasopharyngeal swabs Neutralizing not affect not significantly different observation observations Patient patient population patients patients hospitalized patients with COVID-19 peaked Peripheral blood Placebo presence or absence profile Protein Randomized receive reductions reductions in relationship remained repeated measure respiratory RNA sequencing RNA-Seq RNA-seq. SARS-CoV-2 SARS-COV-2 infection Seroconversion serology serum serum biomarker Serum protein serum proteins serum sample serum samples Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 similarities single dose systemic disease therapeutic Treatment Treatment strategies utility viral-induced was performed was used were used while with COVID-19 [DOI] 10.1186/s12967-022-03345-3 PMC 바로가기 [Article Type] Randomized Controlled Trial